CN1165037A - PH value response medicine controlled release carrier - Google Patents

PH value response medicine controlled release carrier Download PDF

Info

Publication number
CN1165037A
CN1165037A CN 97105119 CN97105119A CN1165037A CN 1165037 A CN1165037 A CN 1165037A CN 97105119 CN97105119 CN 97105119 CN 97105119 A CN97105119 A CN 97105119A CN 1165037 A CN1165037 A CN 1165037A
Authority
CN
China
Prior art keywords
controlled release
chitosan
release preparation
aqueous solution
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 97105119
Other languages
Chinese (zh)
Inventor
姚康德
成国祥
彭涛
尹玉姬
刘静
沈锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN 97105119 priority Critical patent/CN1165037A/en
Publication of CN1165037A publication Critical patent/CN1165037A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pH-responsive controlled releasing carrier for medicine is a chitosan-base gel which is prepared from Chitosan, gelatin and pectin through cross-linking by aldehyde cross-linking agents, and features obvious pH dependency, high biocompatibility and abling to biologically degradate. It can be used for detention-type controlled releasing medicines to avoid toxic' by-effect due to excess dosage.

Description

The pH value response medicine controlled release carrier
The invention belongs to biomedicine, natural macromolecular material.
Intellectual material is the new material with sensing, processing and execution function.High-molecular gel becomes the important research field of intelligent macromolecule material as soft wet part material in recent years.The research that Massachusetts Institute Technology changes mutually from the volume of gel emphatically, illustrate the relation of the collaborative and gel stimulating responsive of macromole interphase interaction, and design on this basis and prepared thermosensitive hydrogel, the super water absorbent gel and the molecular recognition gel [U.S., Phase Transitions ofPolymer Gels and Hetropolymer inResearch in Materials, Annual Report.Massachusetts Institute of Technology, 1996, P.323], Hokkaido, Japan university is by the structural research of synthetic high polymer gel, attempt to optimize its performance, focus on chemical machinery systematic research [Japan, ゲ Le To ぉ け Ru information と conversion, long Tian Yiren, chemistry と industry, 1995,49, P.1395].External this type of research work is mainly based on the synthetic polymer gel, but is subjected to the puzzlement of environment and resource problem.The single chitosan of employing that in the technology of preparing of existing medicine carrying microballoons, has, but substrate property and stimulating responsive are difficult to adjust to OK range [on June 29th, 1989, on February 14th, 1991, a day spy discloses flat 3-34927 for Japan, A 61 K31/60]; The use that has the synthetic high polymer base material, but exist the bad and shortcoming that is difficult to degrade of biocompatibility [Japan, porous micropartical The contains カ プ セ Le modulation と そ application with ぃ The ア ス ピ リ Application, thin well Wen Xiong etc., macromolecule collection of thesis, 1985,42, P.415]; The employing polypeptide class natural polymer base material that has, but there is not desired stimulating responsive [Italy, Gelatin Microspheres:Influence of Preparation Parametersand Thermal Treatment on Chemico-physical and Biopharmaceutical Properties, ElisabettaEsposito, Rita Cortesi and Claudio Nastruzzi, Biomaterials, 1996,17, P.2009].The pH value of patients with gastric disease gastric juice begins to feel under the weather when lower (less than 4) usually, because individual patients and degree difference when taking present pharmaceutical preparation, can't guarantee dosage just in time.If the actual drug consumption is on the low side, then gastric juice pH is still lower, can not remove misery; If actual dosage is more, the pH value of patient's gastric juice has reached just often, left drug still in action or controlled release preparation still discharging the active drug composition, then gastric acid secretion is subjected to excessive inhibition, cause pH too high, can cause a series of toxic and side effects, have toxic and side effects as medicine itself.In addition, pH too high (greater than 7) can cause noxious bacteria upstream in the intestinal to stomach in the what is more important gastric juice, produces such as phenomenons such as ulcer infection.
The objective of the invention is to adopt natural polymer chitosan, gelatin and pectin is the main medicine controlled release carrier of forming, and makes the biocompatibility of carrier and biological degradability be better than containing the system of synthetic high polymer, and has the pH response.
The present invention is raw material, has synthesized chitosan-based gel by aldehydes cross-linking agent co-crosslinking that when pH changed, the interior hydrogen bond of this network dissociated or associates, and makes it to have tangible pH response with natural polymers such as chitosan, gelatin and pectin.Drug delivery system with this preparing gel is tangible pH dependency, is pH response medicine delivery systme, can be developed into oral antiacid, treatment gastric ulcer gastric retention type controlled release preparation.
Consisting of of material of the present invention:
● chitosan 50~100%
● gelatin 0~50%
● pectin 0~10%
● 1.5~30% of cross-linking agent (as formaldehyde, Biformyl, glutaraldehyde etc.) chitosan weight
● medicine (cimetidine, chlorhexidine acetate) 10-50%
1 part of chitosan is dissolved in forms the solution of 2~10% concentration in 2~10% acid (as formic acid, acetic acid, the hydrochloric acid etc.) aqueous solution and placed 24~48 hours, add gelatin, pectin, medicine, under 40~60 ℃ of conditions, fully mix, drip 0.5~5% aldehydes (as formaldehyde, Biformyl, the glutaraldehyde etc.) aqueous solution of 0.3~30ml after cooling, fully mix back film forming drying under 30~80 ℃ of conditions.Consisting of of microsphere of the present invention:
Composition is identical with the invention described above material composition, is added with in addition
● oil (hydrocarbon mixture such as paraffin oil, turbine wet goods) oil-water ratio is 5~20
● emulsifying agent (as sorbitan oleate, polyoxyethylene ether (20) sorbitan oleate etc.)
1/100~1/50 of water
1 part of chitosan and gelatin (pectin, medicine) be dissolved in form 2~10% solution in 2~10% acid (as formic acid, acetic acid, the hydrochloric acid etc.) aqueous solution and placed 24~48 hours, being heated to 40~60 ℃ fully mixes it, place night deaeration again, add that emulsifying agent and oil drip 10~50% aldehydes (as formaldehyde, Biformyl, the glutaraldehyde etc.) reactant aqueous solution 1~4 hour of 0.03~3ml under 30~60 ℃ of temperature, 400-1200rpm mechanical agitation, fully clean with methanol or ether behind the discharging vacuum filtration and dry under 20~80 ℃ of conditions.
Outstanding advantage of the present invention is can be used for the treatment of gastrointestinal tract disease etc., belongs to intelligent controlled release drug carrier of new generation; Especially the release of medicine responds the focus signal and moves, and controlled by gastric juice pH, and pH began to discharge less than 7 o'clock, and stopped to discharge greater than 7 o'clock, can avoid discharging the toxic and side effects that dose excessively causes; The employing natural macromolecular material is a controlled release carrier, good biocompatibility, and biodegradable.
Accompanying drawing-1 is the result of carrying the chitosan-based microsphere of cimetidine pH response releasing research in different pH buffer mediums of the embodiment of the invention 4 preparations, and transverse axis is expressed as the time, and left side 0-60 is minute (min), and the right 1-72 is hour (hr); The longitudinal axis is for discharging percentage ratio (%).Accompanying drawing-2 is the result of carrying the chitosan-based gel releasing research of chlorhexidine acetate of the embodiment of the invention 5 preparations.Transverse axis is time (min) among the figure, and the longitudinal axis is for discharging percentage ratio (%).
The preparation of embodiment 1 chitosan
(1) shrimp (Eriocheir sinensis) shell after the cleaning soaked 5 hours with 5% hydrochloric acid solution, removed the inorganic salt in shelling.
(2) with 10% sodium hydroxide solution digestion 10 hours, remove the protein in shelling.
(3) soaked 5 hours kept at room temperature overnight down at 60~120 ℃ with 50% sodium hydroxide solution.
(4) extremely neutral with hot water wash, 60 ℃ of oven dry down.
The physical and chemical index of chitosan used herein is as follows:
Outward appearance: faint yellow tablet
Moisture content:<8%
Ash:<1.0%
Degree of deacetylation: 63%-92%
Viscosity-average molecular weight: 40~1,600,000
Pb(ppm) :<5
As (ppm): the preparation of<5 embodiment 2 chitosan-based gels
The 1g chitosan is dissolved in 5% acetic acid aqueous solution of 19g and placed 24 hours, add that 1g gelatin and 0.1g pectin fully mix under 50~60 ℃ of conditions, drip after cooling and pour glass plate into behind the 1% glutaraldehyde water solution mix homogeneously of 1ml and make its curtain coating, all volatilize down to liquid 55 ℃ of conditions, obtain chitosan-based gel film.The preparation of embodiment 3 chitosan-based gel micro-balls
1g chitosan and 1g gelatin and 0.1g pectin are dissolved in be heated to about 65 ℃ in 5% acetic acid aqueous solution of 8g and make concentrated solution, place and make its deaeration a night, under 40 ℃ of conditions, stirred earlier 10 minutes after adding 0.4g sorbitan oleate and 200ml paraffin oil with the mixing speed of 400rpm, drip 2ml 25% glutaraldehyde water solution reaction 2 hours, vacuum filtration removes the back reuse methanol cleaning that deoils, bone dry under 60 ℃ of conditions.The preparation of the chitosan-based gel micro-ball of 4 years cimetidine of embodiment
1g chitosan and 1g gelatin and 0.1g pectin are dissolved in be heated to about 65 ℃ in 5% acetic acid aqueous solution of 8g and make concentrated solution, and add that the 0.5g cimetidine fully mixes, place night deaeration, under 30 ℃ of conditions, stirred earlier 20 minutes after adding 0.2g sorbitan oleate and 300ml paraffin oil with the mixing speed of 600rpm, drip 1ml 50% glutaraldehyde water solution reaction 1 hour, the reuse ether was cleaned after vacuum filtration was removed oil removing, at room temperature placed 3 days bone dries.The preparation of 5 years chitosan-based gels of chlorhexidine acetate of embodiment
Be dissolved in the 1g chitosan in the 2%19g acetic acid aqueous solution and placed 24 hours, add that 1g gelatin and 0.1g pectin and 0.2g chlorhexidine acetate fully mix under 50 ℃ of conditions, pour glass plate into behind the 1% glutaraldehyde water solution mix homogeneously of dropping 1ml and make its curtain coating, all volatilize down to liquid 50 ℃ of conditions.The preparation of 6 years chitosan-based gels of cimetidine one chlorhexidine acetate of embodiment
Method has added the 0.5g cimetidine again in addition with embodiment 5.The controlled-release effect of hybrid medicine: o'clock lasting release the in pH<7, pH>7 o'clock burst size seldom.

Claims (3)

1. one kind is the controlled release preparation material of raw material with the natural polymer, the invention is characterized in consisting of of controlled release preparation material: chitosan: 50~100%, gelatin: 0~50%, pectin: 0~10%, aldehydes cross-linking agent (aldehydes such as formaldehyde, Biformyl, glutaraldehyde): be 1.5~30% of chitosan, medicine (cimetidine, chlorhexidine acetate) 10~50%; Consisting of of controlled release preparation microsphere: outside above-mentioned controlled release preparation material was formed, add oil (hydrocarbon mixture such as paraffin oil, turbine wet goods) again: oil-water ratio was 5~20; Emulsifying agent (as sorbitan oleate, polrvinyl chloride ether (20) sorbitan oleate etc.): be 1/100~1/50 of water.
2. described controlled release preparation material of claim 1, it is characterized in that the controlled release preparation material by the preparation technology who forms is: 1 part of chitosan is dissolved in 2~10% acid (as formic acid, acetic acid, hydrochloric acid etc.) form the solution of 2~10% concentration in the aqueous solution, placed 24~48 hours, and added gelatin, pectin, medicine, under 40~60 ℃ of conditions, stir with abundant mixing, drip 0.3~30 part 10~50% aldehydes cross-linking agent aqueous solution after cooling, dry under 30~80 ℃ of conditions.
3. described controlled release preparation material of claim 1, the preparation technology who it is characterized in that the controlled release preparation microsphere is: with 1 part of chitosan and gelatin, pectin, medicine is dissolved in 2~10% acid (as formic acid, acetic acid, hydrochloric acid etc.) forming 2~10% solution in the aqueous solution placed 24~48 hours, being heated to 40~60 ℃ fully mixes it, place night deaeration again, add emulsifying agent and oil and under 30~60 ℃ and 400~1200rpm mechanical agitation, dripped 0.03~3 part of 10~50% aldehydes cross-linking agent aqueous solution reaction 1~4 hour, behind the discharging vacuum filtration with formaldehyde or ether thorough washing and under 20~80 ℃ of conditions drying make.
CN 97105119 1997-06-04 1997-06-04 PH value response medicine controlled release carrier Pending CN1165037A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 97105119 CN1165037A (en) 1997-06-04 1997-06-04 PH value response medicine controlled release carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 97105119 CN1165037A (en) 1997-06-04 1997-06-04 PH value response medicine controlled release carrier

Publications (1)

Publication Number Publication Date
CN1165037A true CN1165037A (en) 1997-11-19

Family

ID=5167677

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 97105119 Pending CN1165037A (en) 1997-06-04 1997-06-04 PH value response medicine controlled release carrier

Country Status (1)

Country Link
CN (1) CN1165037A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100522246C (en) * 2005-03-18 2009-08-05 中国科学院过程工程研究所 Chitosan pellet/microsac and preparation thereof
CN101972232A (en) * 2010-11-01 2011-02-16 山东大学 Eudragit S100 coated curcumin pectin microsphere and preparation method thereof
CN101260191B (en) * 2008-04-01 2011-04-20 武汉大学 Temperature sensitive type chitosan/glutin hydrogel and its preparation method and use
CN106109400A (en) * 2016-07-22 2016-11-16 金陵科技学院 A kind of oral drugs hydrogel slow-released carrier and preparation method and applications
CN106187996A (en) * 2016-07-07 2016-12-07 华南师范大学 A kind of composite aquogel containing rare earth compounding of novel pH response and its preparation method and application
CN107183335A (en) * 2017-07-25 2017-09-22 宿松县大坂农业开发有限公司 A kind of preparation method for promoting to digest ox feed
CN110452054A (en) * 2019-09-10 2019-11-15 山东胜伟盐碱地科技有限公司 A kind of dedicated MULTILAYER COMPOSITE fertiliser granulates of alkaline land improving and preparation method thereof
CN111467320A (en) * 2020-05-13 2020-07-31 四川大学 Microcapsule with pH response and intestinal targeting effects and preparation method thereof

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100522246C (en) * 2005-03-18 2009-08-05 中国科学院过程工程研究所 Chitosan pellet/microsac and preparation thereof
CN101260191B (en) * 2008-04-01 2011-04-20 武汉大学 Temperature sensitive type chitosan/glutin hydrogel and its preparation method and use
CN101972232A (en) * 2010-11-01 2011-02-16 山东大学 Eudragit S100 coated curcumin pectin microsphere and preparation method thereof
CN106187996A (en) * 2016-07-07 2016-12-07 华南师范大学 A kind of composite aquogel containing rare earth compounding of novel pH response and its preparation method and application
CN106187996B (en) * 2016-07-07 2018-11-09 华南师范大学 A kind of composite hydrogel and its preparation method and application containing rare earth compounding of novel pH responses
CN106109400A (en) * 2016-07-22 2016-11-16 金陵科技学院 A kind of oral drugs hydrogel slow-released carrier and preparation method and applications
CN107183335A (en) * 2017-07-25 2017-09-22 宿松县大坂农业开发有限公司 A kind of preparation method for promoting to digest ox feed
CN110452054A (en) * 2019-09-10 2019-11-15 山东胜伟盐碱地科技有限公司 A kind of dedicated MULTILAYER COMPOSITE fertiliser granulates of alkaline land improving and preparation method thereof
CN111467320A (en) * 2020-05-13 2020-07-31 四川大学 Microcapsule with pH response and intestinal targeting effects and preparation method thereof
CN111467320B (en) * 2020-05-13 2021-07-27 四川大学 Microcapsule with pH response and intestinal targeting effects and preparation method thereof

Similar Documents

Publication Publication Date Title
Kumar A review of chitin and chitosan applications
CN1083849C (en) Polysaccharide gel composition
Gupta et al. An overview on chitin and chitosan applications with an emphasis on controlled drug release formulations
JP3337472B2 (en) Wound healing agent
JP3772207B2 (en) Biodegradable biopolymer material, production method thereof, and functional material comprising the polymer material
RU2618329C2 (en) Method of producing hydrogels
US6943154B2 (en) Water insoluble derivatives of polyanionic polysaccharides
CN100509858C (en) Cross-linked polysaccharide composition
JP2002521347A (en) Sustained-release preparation containing anionic polysaccharide
JP2002541308A (en) Aqueous gel-forming system with hydrophobic and hydrophilic components
JP2002504508A (en) Crosslinked high amylose starch with functional groups as sustained release matrix for drug
CN103007336A (en) Fish skin collagen based composite sponge and preparation method thereof
CN102099379B (en) Method for removing impurities from biopolymer material
CN1481907A (en) Carboxymethyl chitosan / carboxymethyl cellulose operative antiblocking film and method for making the same
Zheng et al. pH‐sensitive alginate/soy protein microspheres as drug transporter
KR100324164B1 (en) Layered air-gap sheet of chitosan and process therefor
CN1165037A (en) PH value response medicine controlled release carrier
CN1775302A (en) Chitose-gelatine sponge wound dressing preparing method
CN103785060B (en) Fish skin collagen support loading epidermal growth factors and preparation method thereof
TW477802B (en) Method for preparing hydrophilic porous polymeric materials
CN105801870A (en) Preparation method of polysialic acid-hyaluronic acid composite gel, obtained product and application
CN101450996A (en) Glucose responding type polyphosphazene hydrogel and preparation method thereof
CN115669942A (en) Curcumin-bamboo bird's nest polysaccharide composite microcapsule and preparation method thereof
CN108452366A (en) A kind of gelatin-compounded bleeding-stopping dressing of cod skin and preparation method thereof
Ubaid et al. Synthesis and characterization of pH-sensitive genipin cross-linked chitosan/Eudragit® L100 hydrogel for metformin release study using response surface methodology

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication